BDNF Val66Met polymorphism and serum concentrations of BDNF with smoking in Thai males

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 4925-4933

  Suriyaprom, K ^a   Tungtrongchitr, R ^b   Thawnashom, K ^a   Pimainog, Y ^a  

^a RANGSIT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

BDNF Val66Met polymorphism; Brain derived neurotrophic factor; Cigarette smoking; Hematological parameters

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HEMOGLOBIN; THIOCYANATE;

ADULT; ARTICLE; BDNF GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ERYTHROCYTE COUNT; FEMALE; GENOTYPE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; THAILAND; THROMBOCYTE COUNT; VOLUNTEER; ALLELE; BLOOD; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HEALTH SURVEY; MIDDLE AGED; RISK FACTOR; YOUNG ADULT;

ADULT; ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; RISK FACTORS; SMOKING; THAILAND; YOUNG ADULT;

EID: 84887278266     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.October.24.3     Document Type: Article

References (38)

1. Balfour DJ and Ridley DL (2000). The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? Pharmacol. Biochem. Behav. 66: 79-85.
2. Beuten J, Ma JZ, Payne TJ, Dupont RT, et al. (2005). Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 139B: 73-80.
3. Bhang SY, Choi SW and Ahn JH (2010). Changes in plasma brain-derived neurotrophic factor levels in smokers after smoking cessation. Neurosci. Lett. 468: 7-11.
4. Bhang S, Ahn JH and Choi SW (2011). Brain-derived neurotrophic factor and serotonin transporter gene-linked promoter region genes alter serum levels of brain-derived neurotrophic factor in humans. J. Affect. Disord. 128: 299-304.
5. Breetvelt EJ, Numans ME, Aukes MF, Hoeben W, et al. (2012). The association of the alpha-5 subunit of the nicotinic acetylcholine receptor gene and the brain-derived neurotrophic factor gene with different aspects of smoking behavior. Psychiatr. Genet. 22: 96-98.
6. Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, et al. (2011). Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 36: 228-239.
7. Bus BA, Tendolkar I, Franke B, de Graaf J, et al. (2012). Serum brain-derived neurotrophic factor: determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World J. Biol. Psychiatr. 13: 39-47.
8. Chan KL, Tong KY and Yip SP (2008). Relationship of serum brain-derived neurotrophic factor (BDNF) and health-related lifestyle in healthy human subjects. Neurosci. Lett. 447: 124-128.
9. Correll JA, Noel DM, Sheppard AB, Thompson KN, et al. (2009). Nicotine sensitization and analysis of brain-derived neurotrophic factor in adolescent beta-arrestin-2 knockout mice. Synapse 63: 510-519.
10. Degiampietro P, Peheim E, Drew D, Graf H, et al. (1987). Determination of thiocyanate in plasma and saliva without deproteinisation and its validation as a smoking parameter. J. Clin. Chem. Clin. Biochem. 25: 711-717.
11. Eaton MJ and Whittemore SR (1996). Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS. Exp. Neurol. 140: 105-114.
12. Egan MF, Kojima M, Callicott JH, Goldberg TE, et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
13. Frodl T, Schule C, Schmitt G, Born C, et al. (2007). Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatr. 64: 410-416.
14. Fujimura H, Altar CA, Chen R, Nakamura T, et al. (2002). Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb. Haemost. 87: 728-734.
15. Gass P and Hellweg R (2010). Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders? Int. J. Neuropsychopharmacol. 13: 1-4.
16. Han S, Gelernter J, Luo X and Yang BZ (2010). Meta-analysis of 15 genome-wide linkage scans of smoking behavior. Biol. Psychiatr. 67: 12-19.
17. Harrod SB, Lacy RT, Zhu J, Hughes BA, et al. (2011). Gestational IV nicotine produces elevated brain-derived neurotrophic factor in the mesocorticolimbic dopamine system of adolescent rat offspring. Synapse 65: 1382-1392.
18. Iughetti L, Casarosa E, Predieri B, Patianna V, et al. (2011). Plasma brain-derived neurotrophic factor concentrations in children and adolescents. Neuropeptides 45: 205-211.
19. Karege F, Schwald M and Cisse M (2002). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328: 261-264.
20. Kenny PJ, File SE and Rattray M (2000). Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res. Mol. Brain Res. 85: 234-238.
21. Kim TS, Kim DJ, Lee H and Kim YK (2007). Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neurosci. Lett. 423: 53-57.
22. Lang UE, Sander T, Lohoff FW, Hellweg R, et al. (2007). Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology 190: 433-439.
23. Lang UE, Hellweg R, Sander T and Gallinat J (2009). The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol. Psychiatr. 14: 120-122.
24. Le Foll B, Diaz J and Sokoloff P (2003). Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 47: 176-183.
25. Li MD, Ma JZ, Cheng R, Dupont RT, et al. (2003). A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population. BMC Genet. 4 (Suppl 1): S103.
26. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, et al. (2005). The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 26: 115-123.
27. Mamounas LA, Blue ME, Siuciak JA and Altar CA (1995). Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15: 7929-7939.
28. Matsushita S, Kimura M, Miyakawa T, Yoshino A, et al. (2004). Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin. Exp. Res. 28: 1609-1612.
29. Montag C, Basten U, Stelzel C, Fiebach CJ, et al. (2008). The BDNF Val66Met polymorphism and smoking. Neurosci. Lett. 442: 30-33.
30. Narita M, Aoki K, Takagi M, Yajima Y, et al. (2003). Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119: 767-775.
31. Piccinni A, Marazziti D, Del Debbio A, Bianchi C, et al. (2008). Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol. Int. 25: 819-826.
32. Soulé J, Messaoudi E and Bramham CR (2006). Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem. Soc. Trans. 34: 600-604.
33. Terracciano A, Piras MG, Lobina M, Mulas A, et al. (2011). Genetics of serum BDNF: Meta-analysis of the Val66Met and genome-wide association study. World J. Biol. Psychiatr. [Epub ahead of print].
34. Vaidya VA, Marek GJ, Aghajanian GK and Duman RS (1997). 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17: 2785-2795.
35. Vathesatogkit P and Charoenca N (2011). Tobacco control: lessons learnt in Thailand. Indian J. Public Health 55: 228-233.
36. Wang ZR, Zhou DF, Cao LY, Tan YL, et al. (2007). Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia. Schizophr. Res. 97: 299-301.
37. Winther K and Fornitz GG (1999). The effect of cigarette smoking and nicotine chewing gum on platelet function and fibrinolytic activity. J. Cardiovasc. Risk 6: 303-306.
38. Zhang XY, Xiu MH, Chen da C, Yang FD, et al. (2010). Nicotine dependence and serum BDNF levels in male patients with schizophrenia. Psychopharmacology 212: 301-307.